Cargando…
Intestinal Microbial Metabolites in Ankylosing Spondylitis
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by inflammation of axial joints and the pelvis. It is known that intestinal dysbiosis may exert direct pathogenic effects on gut homeostasis and may act as a triggering factor for the host innate immune system to activate an...
Autores principales: | Scalise, Giuseppe, Ciancio, Antonio, Mauro, Daniele, Ciccia, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347740/ https://www.ncbi.nlm.nih.gov/pubmed/34362137 http://dx.doi.org/10.3390/jcm10153354 |
Ejemplares similares
-
Therapeutic Targets for Ankylosing Spondylitis – Recent Insights and Future Prospects
por: Perrotta, Fabio Massimo, et al.
Publicado: (2022) -
Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders
por: Fiorillo, Maria Teresa, et al.
Publicado: (2019) -
Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021) -
Characteristics of the intestinal microbiome in ankylosing spondylitis
por: Cardoneanu, Anca, et al.
Publicado: (2021) -
Role of the microbiome and its metabolites in ankylosing spondylitis
por: Song, Zi-Yi, et al.
Publicado: (2022)